LYTIR

Company · IMNM

Immunome, Inc.

Name as listed on its exchange; filed with the SEC as Immunome Inc.

Nasdaq's symbol directory lists IMNM on Nasdaq as “Immunome, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders sold on 15 occasions ($16.0M); 1 planned-sale notice; 3 filings by holders of 5% or more; 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 42

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $16.0M in total.Jun: Insider sales $4.3MJul: Insider sales $5.9MAug: Insider sales $5.4MSep: Insider sales $334KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $16.0M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Barchas Isaac sold on 9 days all under a 10b5-1 plan latest Aug 12, 2026 sold $9.9M
  2. Lechleider Robert, Chief Medical Officer sold on 2 days all under a 10b5-1 plan latest Jul 2, 2026 sold $2.3M
  3. Horn Kinney, CHIEF BUSINESS OFFICER sold on 2 days all under a 10b5-1 plan latest Aug 4, 2026 sold $2.3M
  4. Rosett Max, Chief Financial Officer sold on 1 day all under a 10b5-1 plan latest Jun 15, 2026 sold $1.1M
  5. Higgins Jack, Chief Scientific Officer sold on 1 day all under a 10b5-1 plan latest Sep 11, 2026 sold $334K
Every trade (15)
  1. SELLHiggins Jack, Chief Scientific Officer sold Sep 11, 2026 13,200 shares 10b5-1 plan (scheduled) filing $334K
  2. SELLBarchas Isaac sold Aug 12, 2026 11,048 shares 10b5-1 plan (scheduled) filing $301K
  3. SELLBarchas Isaac sold Aug 11, 2026 62,291 shares 10b5-1 plan (scheduled) filing $1.6M
  4. SELLBarchas Isaac sold Aug 10, 2026 10,125 shares 10b5-1 plan (scheduled) filing $264K
  5. SELLBarchas Isaac sold Aug 7, 2026 15,248 shares 10b5-1 plan (scheduled) filing $397K
  6. SELLBarchas Isaac sold Aug 6, 2026 20,840 shares 10b5-1 plan (scheduled) filing $543K
  7. SELLHorn Kinney, CHIEF BUSINESS OFFICER sold Aug 4, 2026 90,616 shares 10b5-1 plan (scheduled) filing $2.3M
  8. SELLBarchas Isaac sold Jul 7, 2026 16,906 shares 10b5-1 plan (scheduled) filing $409K
  9. SELLHorn Kinney, CHIEF BUSINESS OFFICER sold Jul 7, 2026 1,092 shares 10b5-1 plan (scheduled) filing $27K
  10. SELLBarchas Isaac sold Jul 6, 2026 83,094 shares 10b5-1 plan (scheduled) filing $2.0M
  11. SELLBarchas Isaac sold Jul 2, 2026 100,000 shares 2 legs combined 10b5-1 plan (scheduled) filing $2.3M
  12. SELLLechleider Robert, Chief Medical Officer sold Jul 2, 2026 55,000 shares 3 legs combined 10b5-1 plan (scheduled) filing $1.2M
  13. SELLBarchas Isaac sold Jun 30, 2026 101,050 shares 10b5-1 plan (scheduled) filing $2.1M
  14. SELLLechleider Robert, Chief Medical Officer sold Jun 25, 2026 55,000 shares 2 legs combined 10b5-1 plan (scheduled) filing $1.1M
  15. SELLRosett Max, Chief Financial Officer sold Jun 15, 2026 60,000 shares 10b5-1 plan (scheduled) filing $1.1M

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Higgins Jack filed Sep 11, 2026 Officer 13,200 shares planned sale date 09/11/2026 filing $334K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Vanguard Capital Management filed Oct 30, 2026 Schedule 13G passive 5,725,578 shares filing 5.04%
  2. T. Rowe Price Investment Management, Inc. filed Aug 14, 2026 Schedule 13G/A passive 19,676,883 shares filing 17.4%
  3. Sirenia Capital Management LP filed Aug 14, 2026 Schedule 13G/A passive filing 4.3%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Entry into a material definitive agreement; Unregistered sales of equity securities filing Oct 5, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.